{"id":"W2061870732","doi":"10.1097/spc.0b013e3283490418","title":"Current systemic management of metastatic renal cell carcinoma – first line and second line therapy","year":2011,"lang":"en","type":"review","venue":"Current Opinion in Supportive and Palliative Care","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Juravinski Hospital; Juravinski Cancer Centre; St. Joseph's Hospital","funders":"","keywords":"Temsirolimus; Medicine; Sunitinib; Sorafenib; Pazopanib; Everolimus; Renal cell carcinoma; Bevacizumab; Targeted therapy; Oncology; Systemic therapy; Clinical trial; Internal medicine; Intensive care medicine; Discovery and development of mTOR inhibitors; Cancer; PI3K/AKT/mTOR pathway; Chemotherapy; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002245727,0.0008859826,0.002631729,0.0004772871,0.00006498564,0.00001958534,0.0001628203,0.0001647545,0.0001723836],"category_scores_gemma":[0.00001158344,0.000643928,0.0004675034,0.0003727927,0.0001852865,0.00006933541,0.0001878967,0.0006044137,0.00001283151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003111924,"about_ca_system_score_gemma":0.0002595849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000009566426,"about_ca_topic_score_gemma":0.000003920936,"domain_scores_codex":[0.9965014,0.0002692158,0.001464256,0.0009722299,0.0003614595,0.0004314162],"domain_scores_gemma":[0.9976555,0.000168197,0.001063709,0.0004816624,0.0003431407,0.0002878661],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001753704,0.0004699656,0.00838965,0.3187969,0.0004510867,0.00005671557,0.002711763,2.341529e-7,5.326665e-7,0.0001060235,0.0002037888,0.6686379],"study_design_scores_gemma":[0.005261948,0.002484788,0.01380008,0.1221645,0.00221685,0.00005666874,0.001163048,0.000005647143,0.000095277,0.00003782735,0.851825,0.0008883612],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.007152681,0.9868687,0.00005722185,0.000005302755,0.001093619,0.003750271,0.0008553501,0.00001636242,0.0002005377],"genre_scores_gemma":[0.02668387,0.9700777,0.00008454348,0.000003474618,0.0001839419,0.0005877773,0.002235089,0.00007039399,0.00007321413],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.8516212,"threshold_uncertainty_score":0.9996012,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2023019775837762,"score_gpt":0.4001937180149413,"score_spread":0.1978917404311651,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}